The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

Corrigall, William A., Franklin, Keith B. J., Coen, Kathleen M., Clarke, Paul B. S.·1992·Psychopharmacology

Cited by (833)

Items 301–400 of 833

  1. Stimulation of Serotonin2C Receptors Blocks the Hyperactivation of Midbrain Dopamine Neurons Induced by Nicotine Administration
    Massimo Pierucci, Vincenzo Di Matteo, Ennio Esposito · 2004 · Journal of Pharmacology and Experimental Therapeutics
  2. Nicotine-like discriminative stimulus effects of bupropion in rats.
    Jenny L. Wiley, Kari L. LaVecchia, Billy R. Martin, Mohamad Imad Damaj · 2002 · Experimental and Clinical Psychopharmacology
  3. Regulation of nicotinic receptors in rat brain following quasi‐irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine
    El‐Bizri, H., Clarke, P.B.S. · 1994 · British Journal of Pharmacology
  4. The neurobiology of addiction
    Rafael J. Maldonado · 2003 · Springer eBooks
  5. Psychotropic Drugs Used in Anesthesia Practice
    James P. Zacny, Jeffrey L. Galinkin · 1999 · Anesthesiology
  6. Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedure
    Sabina H. L. de Villiers, Nina Lindblom, Genadiy Kalayanov, Sandra Leigh Gordon, Ivan L. Baraznenok, Anna Malmerfelt, Monica M. Marcus, Anette M. Johansson, Torgny H. Svensson · 2010 · Vaccine
  7. Nicotine self-administration
    Kenneth A. Perkins · 1999 · Nicotine & Tobacco Research
  8. Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.
    Michael Lyvers · 1998 · Experimental and Clinical Psychopharmacology
  9. Brain Reward System Activity in Major Depression and Comorbid Nicotine Dependence
    Laura Cárdenas, Lescia K. Tremblay, Claudio A. Naranjo, Nathan Herrmann, Martin H. Zack, Usoa E. Busto · 2002 · Journal of Pharmacology and Experimental Therapeutics
  10. Nicotinic-Receptor Mediation of S(-)Nornicotine-Evoked [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine
    Lihong Teng, Peter Anthony Crooks, Susan T. Buxton, Linda P. Dwoskin · 1997 · Journal of Pharmacology and Experimental Therapeutics
  11. REVIEW: Cognitive effects of nicotine: genetic moderators
    Aryeh I. Herman, Mehmet Sofuoglu · 2010 · Addiction Biology
  12. Nicotine and Behavioral Sensitization
    Danyan Mao, Daniel S. McGehee · 2009 · Journal of Molecular Neuroscience
  13. Nicotine Dependence Predicts Repeated Use of Prescribed Opioids. Prospective Population-based Cohort Study
    Svetlana Ondrasova Skurtveit, Kari Furu, Randi Marie Selmer, Marte Handal, Aage Tverdal · 2010 · Annals of Epidemiology
  14. Effect of a novel nicotinic receptor antagonist, N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats
    Nichole M. Neugebauer‎, Zhenfa Zhang, Peter Anthony Crooks, Linda P. Dwoskin, Michael Thomas Bardo · 2005 · Psychopharmacology
  15. Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation
    Ronald J. Lukas, Ana Z. Muresan, Mohamad Imad Damaj, Bruce E. Blough, Xiaodong Huang, Hernán A. Navarro, S. Wayne Mascarella, Jason Brek Eaton, Syndia Marxer-Miller, Frank Ivy Carroll · 2010 · Journal of Medicinal Chemistry
  16. Place preference conditioning with ventral tegmental injections of cytisine
    Museo, Enrico, Wise, Roy A. · 1994 · Life Sciences
  17. Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus
    William A. Corrigall, Kathleen M. Coen · 1994 · Pharmacology Biochemistry and Behavior
  18. Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine administeredin vivo
    Hiba El-Bizri, Paul B. S. Clarke · 1994 · British Journal of Pharmacology
  19. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA
    Tanja Vihavainen, Toni R. A. Relander, Riikka Leiviskä, Mikko Airavaara, Raimo K. Tuominen, Liisa Ahtee, Petteri T. Piepponen · 2008 · Journal of Neurochemistry
  20. Modulating tobacco smoking rates by dopaminergic stimulation and blockade
    Nicholas H. Caskey, Murray E. Jarvik, William C. Wirshing, Damian C. Madsen, Richard E. Olmstead, Paula N. Iwamoto‐Schaap, Naomi I. Eisenberger, Lorena Huerta, Scott M. Terrace · 2002 · Nicotine & Tobacco Research
  21. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects
    Huibing Tan, Stephanie F. Bishop, Nicole M. Lauzon, Ninglei Sun, Steven R. Laviolette · 2008 · Neuropharmacology
  22. Methylphenidate Enhances the Abuse-Related Behavioral Effects of Nicotine in Rats: Intravenous Self-Administration, Drug Discrimination, and Locomotor Cross-Sensitization
    Thomas E. Wooters, Nichole M. Neugebauer‎, Craig R. Rush, Michael Thomas Bardo · 2007 · Neuropsychopharmacology
  23. Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine
    M. E. M. Benwell, David J.K. Balfour, L.F. Khadra · 1994 · Journal of Molecular Medicine
  24. The Role of CaMKII and ERK Signaling in Addiction
    Wenbin Jia, K. Kawahata, An Cheng, Kohji Fukunaga · 2021 · International Journal of Molecular Sciences
  25. After-effects of self-control: The reward responsivity hypothesis
    Nicholas J. Kelley, Anna J Finley, Brandon J. Schmeichel · 2019 · Cognitive Affective & Behavioral Neuroscience
  26. The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices
    Ying Chen, Thomas J.W. Sharples, Keith Geoffrey Phillips, Giovanni Benedetti, Lisa M. Broad, Ruud Zwart, Emanuele Sher · 2003 · Neuropharmacology
  27. Study of brain uptake and biodistribution of [11C]toluene in non-human primates and mice
    Madina R. Gerasimov, Richard A. Ferrieri, Wynne K. Schiffer, Jean Logan, S. John Gatley, Andrew N. Gifford, David Alexoff, Douglas A. Marsteller, Colleen E. Shea, Victor Garza et al. · 2002 · Life Sciences
  28. Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M
    Araba F. Chintoh · 2003 · Pharmacology Biochemistry and Behavior
  29. Contextual stimuli modulate extinction and reinstatement in rodents self-administering intravenous nicotine
    Victoria C. Wing, Mohammed C. Shoaib · 2008 · Psychopharmacology
  30. Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents
    Linda P. Dwoskin, Sangeetha P. Sumithran, Jun Zhu, Agripina Gabriela Deaciuc, Joshua T. Ayers, Peter Anthony Crooks · 2004 · Bioorganic & Medicinal Chemistry Letters
  31. Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats
    Grażyna Biała, Barbara Budzyńska · 2007 · Pharmacology Biochemistry and Behavior
  32. Concomitant clozapine reduces smoking in patients treated with risperidone
    Ric M. Procyshyn, Gordon Tse, Osric Sin, Sean P. Flynn · 2002 · European Neuropsychopharmacology
  33. Behavioural Pharmacology and Neurobiology of Nicotine Reward and Dependence
    G. Di Chiara · 2000 · Handbook of experimental pharmacology
  34. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress
    Tony Peter George, Christopher D. Verrico, Robert Howard Roth · 1998 · Brain Research
  35. Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response
    Kurt Rasmussen, Mary Jeanne Kallman, David R. Helton · 1997 · Synapse
  36. Systems Level Neuroplasticity in Drug Addiction
    Matthew W. Feltenstein, R.E. See · 2013 · Cold Spring Harbor Perspectives in Medicine
  37. Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment
    Jibran Younis Khokhar, Charmaine S. Ferguson, Andy Z. X. Zhu, Rachel Fynvola Tyndale · 2010 · The Annual Review of Pharmacology and Toxicology
  38. Dopamine receptor (DRD2) genotype‐dependent effects of nicotine on attention and distraction during rapid visual information processing
    David G. Gilbert, Adam Izetelny, Robert C. Radtke, Jonathan J. Hammersley, Norka E. Rabinovich, Travis Jameson, Jodi I. Huggenvik · 2005 · Nicotine & Tobacco Research
  39. Could a common biochemical mechanism underlie addictions?
    C. Betz, D. Mihalic, Marie E Pinto, Robert B. Raffa · 2000 · Journal of Clinical Pharmacy and Therapeutics
  40. Mechanism-based medication development for the treatment of nicotine dependence
    Zheng‐Xiong Xi, Krista J. Spiller, Eliot L. Gardner · 2009 · Acta Pharmacologica Sinica
  41. Recent developments in neuronal nicotinic acetylcholine receptor antagonists
    Linda P. Dwoskin, Rui Xu, Joshua T. Ayers, Peter Anthony Crooks · 2000 · Expert Opinion on Therapeutic Patents
  42. Transgenic mice in drug dependence research
    Emilio Merlo Pich, Mark P. Epping-Jordan · 1998 · Annals of Medicine
  43. A Rodent Model for Nicotine Self-Administration
    William A. Corrigall · 2003 · Humana Press eBooks
  44. Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats
    Naila Ismayilova, Mohammed C. Shoaib · 2010 · Psychopharmacology
  45. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551
    Alexander Kosowski, Gvido Cebers, Aleta Cebere, Ann-Charlott Swanhagen, Sture Liljequist · 2004 · Psychopharmacology
  46. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats
    Dave J. Hayes, Tera M. Mosher, Andrew James Greenshaw · 2008 · Behavioural Brain Research
  47. Nicotine: abused substance and therapeutic agent.
    Jacques Le Houezec · 1998 · PubMed Central
  48. Sex differences in conditioned nicotine reward are age-specific
    Lenoir, Magalie, Starosciak, Amy K., Ledon, Jennifer, Booth, Caitlin, Zakharova, Elena, Wade, Dean, Vignoli, Beatrice, Izenwasser, Sari · 2015 · Pharmacology Biochemistry and Behavior
  49. A Tobacco Reconceptualization in Psychiatry: Toward the Development of Tobacco‐Free Psychiatric Facilities
    Taryn G. Moss, Andrea H. Weinberger, Jennifer C. Vessicchio, Vincenza Mancuso, Sandra J. Cushing, Michael Pett, Kate Kitchen, Peter L. Selby, Tony Peter George · 2010 · American Journal on Addictions
  50. Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation
    Darlene H. Brunzell, J. Michael McIntosh, Roger L. Papke · 2014 · Annals of the New York Academy of Sciences
  51. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
    Allison B. Gold, Caryn E. Lerman · 2012 · Human Genetics
  52. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens
    Shafiqur Rahman, Nichole M. Neugebauer‎, Zhenfa Zhang, Peter Anthony Crooks, Linda P. Dwoskin, Michael Thomas Bardo · 2006 · Neuropharmacology
  53. Neurochemical and behavioural interactions between ibogaine and nicotine in the rat
    Maureen E.M. Benwell, P.E. Holtom, Robert J. Moran, David J.K. Balfour · 1996 · British Journal of Pharmacology
  54. Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference
    Shiva Hashemizadeh, Maryam Sardari, Ameneh Rezayof · 2014 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  55. The α5 Subunit Regulates the Expression and Function of α4*-Containing Neuronal Nicotinic Acetylcholine Receptors in the Ventral-Tegmental Area
    Susmita Chatterjee, Nathan Santos, Joan Y. Holgate, Carolina L. Haass‐Koffler, Frederic Woodward Hopf, Viktor Kharazia, Henry A. Lester, Antonello Bonci, Selena E. Bartlett · 2013 · PLoS ONE
  56. Mechanisms for multiple activity modes of VTA dopamine neurons
    Andrew M. Oster, Philippe Fauré, Boris S Gutkin · 2015 · Frontiers in Computational Neuroscience
  57. Kappa-opioid receptor modulation of nicotine-induced behaviour
    Britta Hahn, Ian P. Stolerman, M. Shoaib · 2000 · Neuropharmacology
  58. Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats
    Narasimha M. Midde, Adrian M. Gomez, Steven B. Harrod, Jun Zhu · 2011 · Pharmacology Biochemistry and Behavior
  59. Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice
    Hongwen Zhu, Moon-Sook Lee, Soh Agatsuma, Noboru Hiroi · 2007 · Human Molecular Genetics
  60. Nicotinic acetylcholine receptor ligands, a patent review (2006 – 2011)
    Daniela Gündisch, Christoph Eibl · 2011 · Expert Opinion on Therapeutic Patents
  61. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h
    Vincenzo Teneggi, Stephen T. Tiffany, Lisa Squassante, Stefano Milleri, Luigi Ziviani, Alan Bye · 2005 · Psychopharmacology
  62. Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats
    Nobuyoshi Suto, Roy A. Wise, Paul Vezina · 2011 · Neuroscience Letters
  63. Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists
    Grażyna Biała, Barbara Weglińska · 2005 · Pharmacological Research
  64. Brain sites mediating the discriminative stimulus effects of nicotine in rats
    Mohammed C. Shoaib, Ian P. Stolerman · 1996 · Behavioural Brain Research
  65. Ibogaine and the dopaminergic response to nicotine
    I.M. Maisonneuve, S.D. Glick, Gina L Mann, C. R. Deibel · 1997 · Psychopharmacology
  66. Nicotine provokes impulsive-like action by stimulating α4β2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex
    Iku Tsutsui‐Kimura, Yu Ohmura, Takeshi Izumi, Taku Yamaguchi, Takayuki Yoshida, Mitsuhiro Yoshioka · 2010 · Psychopharmacology
  67. Nicotinic antagonist effects on functional attention networks
    Renate Thienel, Bianca Voß, Thilo Kellermann, Martina Reske, Sarah Halfter, Abigail J. Sheldrick, Katrin Radenbach, Ute Habel, Nadim Jon Shah, Ulrich Schall et al. · 2009 · The International Journal of Neuropsychopharmacology
  68. Menthol facilitates dopamine-releasing effect of nicotine in rat nucleus accumbens
    Meiyu Zhang, Erin Harrison, Lisa Biswas, Thuy Tran, Xiu Liu · 2018 · Pharmacology Biochemistry and Behavior
  69. Neurobiology of drug addiction.
    George F. Koob, S. Barak Caine, Petri Hyytiä, Athina Markou, Loren H. Parsons, Amanda J. Roberts, Gery Schulteis, Friedbert Weiss · 1999 · American Psychological Association eBooks
  70. The influence of mecamylamine on ethanol and sucrose self-administration
    Matthew M. Ford, Andrea M. Fretwell, Jeffrey D. Nickel, Gregory P. Mark, Moriah N. Strong, Naomi Yoneyama, Deborah A. Finn · 2009 · Neuropharmacology
  71. Role of Ventral Striatal Dopamine D1 Receptor in Cigarette Craving
    Fumihiko Yasuno, Miho Ota, Kiyoshi Ando, Tomomichi Ando, Jun Maeda, Tetsuya Ichimiya, Akihiro Takano, TALANT K. DORONBEKOV, Yota Fujimura, Shoko Nozaki et al. · 2006 · Biological Psychiatry
  72. Long-Term Upregulation of Protein Kinase A and Adenylate Cyclase Levels in Human Smokers
    Bruce T. Hope, Deepti R. Nagarkar, Sherry S. Leonard, Roy A. Wise · 2007 · Journal of Neuroscience
  73. Nicotine and brain-stimulation reward: Interactions with morphine, amphetamine and pimozide
    David Huston-Lyons, Molly Sarkar, Conan H. Kornetsky · 1993 · Pharmacology Biochemistry and Behavior
  74. Whole tobacco smoke extracts to model tobacco dependence in animals
    Katharine Alexandra Brennan, Murray Laugesen, Penelope Truman · 2014 · Neuroscience & Biobehavioral Reviews
  75. The Necessity of α4* Nicotinic Receptors in Nicotine-Driven Behaviors: Dissociation Between Reinforcing and Motor Effects of Nicotine
    Elizabeth Cahir, Katie Pillidge, John Drago, Andrew John Lawrence · 2011 · Neuropsychopharmacology
  76. Nicotine Normalizes Increased Prefrontal Cortical Dopamine D1 Receptor Binding and Decreased Working Memory Performance Produced by Repeated Pretreatment with MK-801: A PET Study in Conscious Monkeys
    Hideo Tsukada, Katsumasa Miyasato, Shingo Nishiyama, Dai Fukumoto, Takeharu Kakiuchi, Edward F. Domino · 2005 · Neuropsychopharmacology
  77. Rimonabant: A cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors
    Serena Tonstad · 2006 · Nutrition Metabolism and Cardiovascular Diseases
  78. Genetic Variation in the Dopamine Pathway and Smoking Cessation
    Sean P. David, Marcus Robert Munafo · 2008 · Pharmacogenomics
  79. The Influence of Personality on Nicotine Craving: A Hierarchical Multivariate Statistical Prediction Model
    Martin Reuter, Petra Netter · 2001 · Neuropsychobiology
  80. The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response
    Mohammad Mahdi Nasehi, Fatemeh Mafi, Shahrbanoo Oryan, Sima Nasri, Mohammad‐Reza Zarrindast · 2011 · Pharmacology Biochemistry and Behavior
  81. Amphetamine Administration into the Ventral Striatum Facilitates Behavioral Interaction with Unconditioned Visual Signals in Rats
    Rick S. Shin, Junran Cao, Sierra M. Webb, Satoshi Ikemoto · 2010 · PLoS ONE
  82. Social Defeat Stress, Sex, and Addiction-Like Behaviors
    Akiko Shimamoto · 2018 · International review of neurobiology
  83. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine
    Valeria Tronci, Svetlana Vronskaya, Nicholas Montgomery, Daniela Mura, David J.K. Balfour · 2010 · Psychopharmacology
  84. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices11Abbreviations: DA, dopamine; and DHβE, dihydro-β-erythroidine.
    Thomas A. Green, Peter Anthony Crooks, Michael Thomas Bardo, Linda P. Dwoskin · 2001 · Biochemical Pharmacology
  85. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: Therapeutic implications in Parkinson's disease and abuse liability
    Andrea Giuffrida, Lance Richard McMahon · 2009 · Prostaglandins & Other Lipid Mediators
  86. Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water
    Helena Gäddnäs, Kirsi Pietilä, Petteri T. Piepponen, Liisa Ahtee · 2001 · Pharmacology Biochemistry and Behavior
  87. Nicotine-induced enhancement of responding for conditioned reinforcement in rats: Role of prior nicotine exposure and α4β2 nicotinic receptors
    Elizabeth Glenn Guy, Paul J. Fletcher · 2012 · Psychopharmacology
  88. Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control
    Tongyuan Hu, Zhongli Yang, Ming D. Li · 2018 · Journal of Neuroimmune Pharmacology
  89. Neuroadaptive Changes Associated with Smoking: Structural and Functional Neural Changes in Nicotine Dependence
    Chantal Martin-Söelch · 2013 · Brain Sciences
  90. The Role of Mesoaccumbens Dopamine in Nicotine Dependence
    David J.K. Balfour · 2015 · Current topics in behavioral neurosciences
  91. Operant Ethanol Self-Administration After Nicotine Treatment and Withdrawal
    Roser A. Nadal, H. H. Samson · 1999 · Alcohol
  92. (−)-Nornicotine Partially Substitutes for (+)-Amphetamine in a Drug Discrimination Paradigm in Rats
    Michael Thomas Bardo, Rick A. Bevins, Jennifer E. Klebaur, Peter Anthony Crooks, Linda P. Dwoskin · 1997 · Pharmacology Biochemistry and Behavior
  93. Disrupting Nicotine Reinforcement
    Jed E. Rose · 2008 · Annals of the New York Academy of Sciences
  94. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats
    Manoranjan S. D’Souza, Athina Markou · 2011 · Neuropharmacology
  95. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice
    Cyrille Vaillend, Arielle Ungerer, Jean‐Marie Billard · 1999 · Synapse
  96. Mecamylamine but not the α7 receptor antagonist α‐bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine
    F. E. J. Kempsill, Judith A. Pratt · 2000 · British Journal of Pharmacology
  97. Dopamine Receptor Blockade Modulates the Rewarding and Aversive Properties of Nicotine via Dissociable Neuronal Activity Patterns in the Nucleus Accumbens
    Ninglei Sun, Steven R. Laviolette · 2014 · Neuropsychopharmacology
  98. Age-related changes in nicotine response of cholinergic and non-cholinergic laterodorsal tegmental neurons: Implications for the heightened adolescent susceptibility to nicotine addiction
    Mark H. Christensen, Masaru Ishibashi, Michael Lund Nielsen, Christopher S. Leonard, Kristi A. Kohlmeier · 2014 · Neuropharmacology
  99. Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
    Heath D. Schmidt, Laura E. Rupprecht, Nii Addy · 2018 · Complex Psychiatry
  100. Cellular events in nicotine addiction
    Rachel E. Penton, Robin A. J. Lester · 2009 · Seminars in Cell and Developmental Biology